MedPath

Chronic Pain and Opioid Dependence Assessment and Treatment

Not Applicable
Completed
Conditions
Chronic Pain
Opioid Dependency
Interventions
Behavioral: Integrated Cognitive Behavioral Therapy
Registration Number
NCT00727675
Lead Sponsor
Yale University
Brief Summary

This study involves the development of an integrated psychotherapy that addresses both chronic pain and opioid dependence(POD).

Detailed Description

To conduct a pre-pilot study with 20 POD patients to a) evaluate the acceptability and potential efficacy of specific sessions (i.e., reduced illicit opioid use as assessed by urine toxicology and self-report findings, and decreased pain as evidenced by attenuated pain intensity and pain interference on self-report measures from baseline throughout treatment) for inclusion in integrated Cognitive Behavioral Therapy (CBT) for POD and the sequence of sessions, b) assess patients' satisfaction with integrated CBT as evidenced by qualitative feedback from individual exit interviews, and c) develop and modify initial therapist training and process rating measures. Products will include a) a manual for integrated CBT for POD to be used in opioid treatment programs and primary care settings with POD patients, b) therapist training materials, and c) process rating instruments.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • at least 18 years of age
  • currently in Methadone Maintenance Treatment (MMT) at the APT Foundation in New Haven, CT
  • opioid dependence
  • experience moderate to severe chronic pain
Read More
Exclusion Criteria
  • current suicide or homicide risk
  • are unable to complete the informed consent or surveys because of psychiatric impairment
  • have cognitive impairment
  • are unable to read or understand English
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Integrated Cognitive Behavioral TherapyIntegrated Cognitive Behavioral Therapy for pain reduction and opioid dependence.
Primary Outcome Measures
NameTimeMethod
Reduced illicit opioid use and pain12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yale University School of Medicine

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath